Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Whang
HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
ST6Gal-I Sialyltransferase Promotes Chemoresistance in Pancreatic Ductal Adenocarcinoma by Abrogating Gemcitabine-Mediated DNA Damage
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study
British Journal of Cancer
Cancer Research
Oncology
Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
Cancer Research
Cancer Research
Oncology
Overexpression of HMGA1 Promotes Anoikis Resistance and Constitutive Akt Activation in Pancreatic Adenocarcinoma Cells
British Journal of Cancer
Cancer Research
Oncology
GPRC5A Is a Potential Oncogene in Pancreatic Ductal Adenocarcinoma Cells That Is Upregulated by Gemcitabine With Help From HuR
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Deoxycitidine Kinase Is Associated With Prolonged Survival After Adjuvant Gemcitabine for Resected Pancreatic Adenocarcinoma
Cancer
Cancer Research
Oncology
P8 Is a New Target of Gemcitabine in Pancreatic Cancer Cells
Clinical Cancer Research
Cancer Research
Oncology
Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Case Report of Gemcitabine-Induced Steatohepatitis Associated With Adjuvant Monotherapy for Pancreatic Adenocarcinoma
The Medicine Forum